ZA200200552B - Skin care composition. - Google Patents

Skin care composition. Download PDF

Info

Publication number: ZA200200552B
Authority: ZA; South Africa
Prior art keywords: skin; cla; composition; boosting; cosmetic
Prior art date: 1999-07-30

Application number

ZA200200552A

Other languages

English (en)

Inventor

Karen Elizabeth Barrett

Martin Richard Green

Heng-Long Hu

Preyesh Parmar

Jonathan Richard Powell

Anthony Vincent Rawlings

Original Assignee

Unilever Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-30

Filing date

2002-01-22

Publication date

2003-03-26

2002-01-22 Application filed by Unilever Plc filed Critical Unilever Plc

2003-03-26 Publication of ZA200200552B publication Critical patent/ZA200200552B/en

Links

239000000203 mixture Substances 0.000 title claims abstract description 74
150000002989 phenols Chemical class 0.000 claims abstract description 28
OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 27
229940108924 conjugated linoleic acid Drugs 0.000 claims abstract description 25
JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims abstract description 22
230000000699 topical effect Effects 0.000 claims abstract description 15
230000000475 sunscreen effect Effects 0.000 claims abstract description 13
239000000516 sunscreening agent Substances 0.000 claims abstract description 13
230000037307 sensitive skin Effects 0.000 claims abstract description 11
239000002537 cosmetic Substances 0.000 claims description 24
238000000034 method Methods 0.000 claims description 20
102000004237 Decorin Human genes 0.000 claims description 16
108090000738 Decorin Proteins 0.000 claims description 16
230000008901 benefit Effects 0.000 claims description 15
-1 conjugated linoleic acid compound Chemical class 0.000 claims description 15
238000004519 manufacturing process Methods 0.000 claims description 14
WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 13
229940030275 epigallocatechin gallate Drugs 0.000 claims description 13
WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 12
210000002374 sebum Anatomy 0.000 claims description 12
230000028327 secretion Effects 0.000 claims description 11
238000007665 sagging Methods 0.000 claims description 10
102000008186 Collagen Human genes 0.000 claims description 9
108010035532 Collagen Proteins 0.000 claims description 9
206010051246 Photodermatosis Diseases 0.000 claims description 9
229920001436 collagen Polymers 0.000 claims description 9
230000002708 enhancing effect Effects 0.000 claims description 9
230000036548 skin texture Effects 0.000 claims description 8
230000017423 tissue regeneration Effects 0.000 claims description 8
239000002253 acid Substances 0.000 claims description 7
TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 claims description 7
235000006539 genistein Nutrition 0.000 claims description 7
229940045109 genistein Drugs 0.000 claims description 7
ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 claims description 7
241000030538 Thecla Species 0.000 claims description 6
150000001875 compounds Chemical class 0.000 claims description 5
239000003814 drug Substances 0.000 claims description 3
JBYXPOFIGCOSSB-UQGDGPGGSA-N rumenic acid Chemical compound CCCCCC\C=C/C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-UQGDGPGGSA-N 0.000 claims description 3
206010013786 Dry skin Diseases 0.000 claims description 2
235000010469 Glycine max Nutrition 0.000 claims description 2
239000000284 extract Substances 0.000 claims description 2
229940094952 green tea extract Drugs 0.000 claims 1
235000020688 green tea extract Nutrition 0.000 claims 1
230000037303 wrinkles Effects 0.000 abstract description 6
210000003491 skin Anatomy 0.000 description 66
210000004027 cell Anatomy 0.000 description 20
210000002950 fibroblast Anatomy 0.000 description 17
239000003921 oil Substances 0.000 description 17
235000019198 oils Nutrition 0.000 description 16
239000000047 product Substances 0.000 description 16
235000014113 dietary fatty acids Nutrition 0.000 description 15
239000000194 fatty acid Substances 0.000 description 15
229930195729 fatty acid Natural products 0.000 description 15
150000004665 fatty acids Chemical class 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
238000003556 assay Methods 0.000 description 10
239000003981 vehicle Substances 0.000 description 10
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 9
239000012528 membrane Substances 0.000 description 9
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 8
230000002500 effect on skin Effects 0.000 description 8
PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
210000002966 serum Anatomy 0.000 description 8
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 7
230000000694 effects Effects 0.000 description 7
239000000126 substance Substances 0.000 description 7
238000004458 analytical method Methods 0.000 description 6
ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 6
206010040829 Skin discolouration Diseases 0.000 description 5
244000269722 Thea sinensis Species 0.000 description 5
230000003712 anti-aging effect Effects 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
239000003636 conditioned culture medium Substances 0.000 description 5
239000002609 medium Substances 0.000 description 5
235000013824 polyphenols Nutrition 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
239000011541 reaction mixture Substances 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
229920001213 Polysorbate 20 Polymers 0.000 description 4
ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 4
HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 4
150000007513 acids Chemical class 0.000 description 4
230000032683 aging Effects 0.000 description 4
230000008021 deposition Effects 0.000 description 4
238000010790 dilution Methods 0.000 description 4
239000012895 dilution Substances 0.000 description 4
150000002148 esters Chemical class 0.000 description 4
229930003935 flavonoid Natural products 0.000 description 4
150000002215 flavonoids Chemical class 0.000 description 4
235000017173 flavonoids Nutrition 0.000 description 4
LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
235000009569 green tea Nutrition 0.000 description 4
MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 4
239000007788 liquid Substances 0.000 description 4
239000000463 material Substances 0.000 description 4
238000000199 molecular distillation Methods 0.000 description 4
229910052757 nitrogen Inorganic materials 0.000 description 4
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
150000008442 polyphenolic compounds Chemical class 0.000 description 4
235000005875 quercetin Nutrition 0.000 description 4
229960001285 quercetin Drugs 0.000 description 4
150000003626 triacylglycerols Chemical class 0.000 description 4
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 description 3
108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 3
239000004367 Lipase Substances 0.000 description 3
102000004882 Lipase Human genes 0.000 description 3
108090001060 Lipase Proteins 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
244000309466 calf Species 0.000 description 3
ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 3
235000005487 catechin Nutrition 0.000 description 3
235000007240 daidzein Nutrition 0.000 description 3
230000006872 improvement Effects 0.000 description 3
230000002757 inflammatory effect Effects 0.000 description 3
230000028709 inflammatory response Effects 0.000 description 3
235000019421 lipase Nutrition 0.000 description 3
WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 3
235000007625 naringenin Nutrition 0.000 description 3
229940117954 naringenin Drugs 0.000 description 3
238000000926 separation method Methods 0.000 description 3
230000002195 synergetic effect Effects 0.000 description 3
PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 2
ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
101100328086 Caenorhabditis elegans cla-1 gene Proteins 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
241000235395 Mucor Species 0.000 description 2
241000235403 Rhizomucor miehei Species 0.000 description 2
IOUUIFSIQMVYKP-UHFFFAOYSA-N Tetradecyl acetate Chemical compound CCCCCCCCCCCCCCOC(C)=O IOUUIFSIQMVYKP-UHFFFAOYSA-N 0.000 description 2
NFXWJYUDIOHFAW-UHFFFAOYSA-N acetic acid;tetradecanoic acid Chemical compound CC(O)=O.CCCCCCCCCCCCCC(O)=O NFXWJYUDIOHFAW-UHFFFAOYSA-N 0.000 description 2
150000001298 alcohols Chemical class 0.000 description 2
230000003110 anti-inflammatory effect Effects 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
235000006708 antioxidants Nutrition 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
239000012965 benzophenone Substances 0.000 description 2
150000008366 benzophenones Chemical class 0.000 description 2
239000000872 buffer Substances 0.000 description 2
239000002775 capsule Substances 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
229950001002 cianidanol Drugs 0.000 description 2
XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
229960002986 dinoprostone Drugs 0.000 description 2
238000004821 distillation Methods 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
229930182497 flavan-3-ol Natural products 0.000 description 2
150000002206 flavan-3-ols Chemical class 0.000 description 2
YTAQZPGBTPDBPW-UHFFFAOYSA-N flavonoid group Chemical class O1C(C(C(=O)C2=CC=CC=C12)=O)C1=CC=CC=C1 YTAQZPGBTPDBPW-UHFFFAOYSA-N 0.000 description 2
HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 2
150000002216 flavonol derivatives Chemical class 0.000 description 2
235000011957 flavonols Nutrition 0.000 description 2
235000013305 food Nutrition 0.000 description 2
210000003953 foreskin Anatomy 0.000 description 2
238000009472 formulation Methods 0.000 description 2
235000004515 gallic acid Nutrition 0.000 description 2
229940074391 gallic acid Drugs 0.000 description 2
239000000499 gel Substances 0.000 description 2
235000011187 glycerol Nutrition 0.000 description 2
230000005484 gravity Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
125000004356 hydroxy functional group Chemical group O* 0.000 description 2
208000000069 hyperpigmentation Diseases 0.000 description 2
230000003810 hyperpigmentation Effects 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
150000002515 isoflavone derivatives Chemical class 0.000 description 2
235000008696 isoflavones Nutrition 0.000 description 2
229930013032 isoflavonoid Natural products 0.000 description 2
150000003817 isoflavonoid derivatives Chemical class 0.000 description 2
235000012891 isoflavonoids Nutrition 0.000 description 2
235000020778 linoleic acid Nutrition 0.000 description 2
150000002632 lipids Chemical group 0.000 description 2
238000000329 molecular dynamics simulation Methods 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
239000012071 phase Substances 0.000 description 2
235000009048 phenolic acids Nutrition 0.000 description 2
150000007965 phenolic acids Chemical class 0.000 description 2
239000000843 powder Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
239000002904 solvent Substances 0.000 description 2
239000011550 stock solution Substances 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
QGVLYPPODPLXMB-UBTYZVCOSA-N (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-5H-cyclopropa[3,4]benzo[1,2-e]azulen-5-one Chemical compound C1=C(CO)C[C@]2(O)C(=O)C(C)=C[C@H]2[C@@]2(O)[C@H](C)[C@@H](O)[C@@]3(O)C(C)(C)[C@H]3[C@@H]21 QGVLYPPODPLXMB-UBTYZVCOSA-N 0.000 description 1
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical class OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
KKBIDVILXNDFLH-UHFFFAOYSA-N 3-phenyl-3,4-dihydro-2h-chromen-4-ol Chemical class C1OC2=CC=CC=C2C(O)C1C1=CC=CC=C1 KKBIDVILXNDFLH-UHFFFAOYSA-N 0.000 description 1
AIIUVZXJSAAETG-UHFFFAOYSA-N 3-phenylchromene-2,4-dione Chemical class O=C1OC2=CC=CC=C2C(=O)C1C1=CC=CC=C1 AIIUVZXJSAAETG-UHFFFAOYSA-N 0.000 description 1
244000291564 Allium cepa Species 0.000 description 1
235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
235000014143 Camellia sinensis var assamica Nutrition 0.000 description 1
240000008441 Camellia sinensis var. assamica Species 0.000 description 1
244000020518 Carthamus tinctorius Species 0.000 description 1
235000003255 Carthamus tinctorius Nutrition 0.000 description 1
229920000298 Cellophane Polymers 0.000 description 1
DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
241000207199 Citrus Species 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
206010014970 Ephelides Diseases 0.000 description 1
241000159512 Geotrichum Species 0.000 description 1
101001000206 Homo sapiens Decorin Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
208000003351 Melanosis Diseases 0.000 description 1
CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
241000219925 Oenothera Species 0.000 description 1
235000004496 Oenothera biennis Nutrition 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
208000012641 Pigmentation disease Diseases 0.000 description 1
235000019485 Safflower oil Nutrition 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
206010040880 Skin irritation Diseases 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
235000006468 Thea sinensis Nutrition 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
102000003425 Tyrosinase Human genes 0.000 description 1
108060008724 Tyrosinase Proteins 0.000 description 1
QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
150000008062 acetophenones Chemical class 0.000 description 1
239000012190 activator Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000004378 air conditioning Methods 0.000 description 1
239000003513 alkali Substances 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
150000001340 alkali metals Chemical class 0.000 description 1
229910052784 alkaline earth metal Inorganic materials 0.000 description 1
JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
150000003863 ammonium salts Chemical class 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
235000021342 arachidonic acid Nutrition 0.000 description 1
229940114079 arachidonic acid Drugs 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
238000003149 assay kit Methods 0.000 description 1
229930015036 aurone Natural products 0.000 description 1
150000001530 aurones Chemical class 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
150000004054 benzoquinones Chemical class 0.000 description 1
230000008436 biogenesis Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
230000001914 calming effect Effects 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000004359 castor oil Substances 0.000 description 1
235000019438 castor oil Nutrition 0.000 description 1
150000001765 catechin Chemical class 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
229940106189 ceramide Drugs 0.000 description 1
ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
150000001789 chalcones Chemical class 0.000 description 1
235000005513 chalcones Nutrition 0.000 description 1
150000004777 chromones Chemical class 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
239000013256 coordination polymer Substances 0.000 description 1
235000001671 coumarin Nutrition 0.000 description 1
150000004775 coumarins Chemical class 0.000 description 1
239000006071 cream Substances 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
239000007854 depigmenting agent Substances 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
229960001760 dimethyl sulfoxide Drugs 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
229940079593 drug Drugs 0.000 description 1
229940126534 drug product Drugs 0.000 description 1
230000037336 dry skin Effects 0.000 description 1
JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
229960005135 eicosapentaenoic acid Drugs 0.000 description 1
235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
239000003974 emollient agent Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
235000012734 epicatechin Nutrition 0.000 description 1
IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
235000013861 fat-free Nutrition 0.000 description 1
150000002190 fatty acyls Chemical group 0.000 description 1
238000001914 filtration Methods 0.000 description 1
229930003944 flavone Natural products 0.000 description 1
150000002213 flavones Chemical class 0.000 description 1
235000011949 flavones Nutrition 0.000 description 1
230000037406 food intake Effects 0.000 description 1
239000012634 fragment Substances 0.000 description 1
235000021588 free fatty acids Nutrition 0.000 description 1
VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
235000020664 gamma-linolenic acid Nutrition 0.000 description 1
229960002733 gamolenic acid Drugs 0.000 description 1
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
102000045840 human DCN Human genes 0.000 description 1
239000003906 humectant Substances 0.000 description 1
229930005346 hydroxycinnamic acid Natural products 0.000 description 1
DEDGUGJNLNLJSR-UHFFFAOYSA-N hydroxycinnamic acid group Chemical class OC(C(=O)O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 1
235000010359 hydroxycinnamic acids Nutrition 0.000 description 1
238000010191 image analysis Methods 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000007794 irritation Effects 0.000 description 1
150000002512 isocoumarins Chemical class 0.000 description 1
IQZZFVDIZRWADY-UHFFFAOYSA-N isocumarine Natural products C1=CC=C2C(=O)OC=CC2=C1 IQZZFVDIZRWADY-UHFFFAOYSA-N 0.000 description 1
NNQSGBRGJHSRFN-UHFFFAOYSA-N isoflavan Chemical class C1OC2=CC=CC=C2CC1C1=CC=CC=C1 NNQSGBRGJHSRFN-UHFFFAOYSA-N 0.000 description 1
125000004388 isoflavanoid group Chemical group 0.000 description 1
238000002955 isolation Methods 0.000 description 1
229930013686 lignan Natural products 0.000 description 1
150000005692 lignans Chemical class 0.000 description 1
235000009408 lignans Nutrition 0.000 description 1
239000006210 lotion Substances 0.000 description 1
239000003550 marker Substances 0.000 description 1
210000002752 melanocyte Anatomy 0.000 description 1
238000002156 mixing Methods 0.000 description 1
229930014805 neoflavone Natural products 0.000 description 1
150000002802 neoflavones Chemical class 0.000 description 1
229930182783 neolignan Natural products 0.000 description 1
VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
239000003605 opacifier Substances 0.000 description 1
239000002304 perfume Substances 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
229930015698 phenylpropene Natural products 0.000 description 1
QROGIFZRVHSFLM-UHFFFAOYSA-N phenylpropene group Chemical class C1(=CC=CC=C1)C=CC QROGIFZRVHSFLM-UHFFFAOYSA-N 0.000 description 1
QGVLYPPODPLXMB-QXYKVGAMSA-N phorbol Natural products C[C@@H]1[C@@H](O)[C@]2(O)[C@H]([C@H]3C=C(CO)C[C@@]4(O)[C@H](C=C(C)C4=O)[C@@]13O)C2(C)C QGVLYPPODPLXMB-QXYKVGAMSA-N 0.000 description 1
239000000049 pigment Substances 0.000 description 1
230000019612 pigmentation Effects 0.000 description 1
238000011020 pilot scale process Methods 0.000 description 1
239000000419 plant extract Substances 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
235000008476 powdered milk Nutrition 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
239000003380 propellant Substances 0.000 description 1
238000011002 quantification Methods 0.000 description 1
FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000011506 response to oxidative stress Effects 0.000 description 1
235000005493 rutin Nutrition 0.000 description 1
IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
229960004555 rutoside Drugs 0.000 description 1
239000003813 safflower oil Substances 0.000 description 1
235000005713 safflower oil Nutrition 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
238000007127 saponification reaction Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
229920002545 silicone oil Polymers 0.000 description 1
230000037075 skin appearance Effects 0.000 description 1
210000001626 skin fibroblast Anatomy 0.000 description 1
230000036556 skin irritation Effects 0.000 description 1
231100000475 skin irritation Toxicity 0.000 description 1
235000019333 sodium laurylsulphate Nutrition 0.000 description 1
239000007787 solid Substances 0.000 description 1
235000021286 stilbenes Nutrition 0.000 description 1
150000001629 stilbenes Chemical class 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
230000037072 sun protection Effects 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000011885 synergistic combination Substances 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
239000002383 tung oil Substances 0.000 description 1
235000021122 unsaturated fatty acids Nutrition 0.000 description 1
150000004670 unsaturated fatty acids Chemical class 0.000 description 1
150000007964 xanthones Chemical class 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Gerontology & Geriatric Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA200200552A 1999-07-30 2002-01-22 Skin care composition. ZA200200552B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9918028.3A GB9918028D0 (en)	1999-07-30	1999-07-30	Skin care composition

Publications (1)

Publication Number	Publication Date
ZA200200552B true ZA200200552B (en)	2003-03-26

Family

ID=10858310

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200200552A ZA200200552B (en)	1999-07-30	2002-01-22	Skin care composition.

Country Status (15)

Country	Link
US (1)	US6551602B1 (de)
EP (1)	EP1198222B1 (de)
JP (1)	JP2003505492A (de)
KR (1)	KR100729315B1 (de)
CN (1)	CN1195492C (de)
AT (1)	ATE304841T1 (de)
AU (1)	AU776606B2 (de)
CA (1)	CA2391343C (de)
DE (1)	DE60022758T2 (de)
ES (1)	ES2248109T3 (de)
GB (1)	GB9918028D0 (de)
MX (1)	MXPA02001028A (de)
TW (1)	TWI230071B (de)
WO (1)	WO2001008652A1 (de)
ZA (1)	ZA200200552B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0105622D0 (en) *	2001-03-07	2001-04-25	Natural Asa	Compositions
FR2822068B1 (fr) *	2001-03-15	2004-12-17	Pharmascience Lab	Composition topique comprenant une association de lipides furanniques d'avocat et d'isoflavones
DE10121375B4 (de) *	2001-05-02	2014-01-16	Beiersdorf Ag	Verwendung von Isoflavonoiden in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut
FR2829927B1 (fr) *	2001-09-21	2004-09-24	Svr Lab	Nouvelles compositions cosmetiques et leur procede d'obtention
US6677470B2 (en) *	2001-11-20	2004-01-13	Natural Asa	Functional acylglycerides
WO2003057700A1 (en) *	2001-12-28	2003-07-17	Sansho Seiyaku Co., Ltd.	Compositions containing pigmentatin inhibitor, use thereof and process for producing the same
FR2834639A1 (fr) *	2002-01-11	2003-07-18	Medix Lab	Composition comprenant en association au moins un flavonoide et au moins une huile vegetale, son utilisation comme agent dermatologique ou dermatocosmetique
US7314634B2 (en) *	2002-02-22	2008-01-01	Steven Hernandez	Use of polyphenols to treat skin conditions
EP1503633A1 (de) *	2002-04-24	2005-02-09	Unilever N.V.	Verwendung von hopfenbestandteilen in lebensmitteln
DE10218476A1 (de) *	2002-04-25	2003-11-06	Beiersdorf Ag	Zubereitungen mit Lignanen
FI20021184A7 (fi)	2002-06-19	2003-12-20	Hormos Medical Ltd	Lignaanivalmisteita
JP3926711B2 (ja) *	2002-08-30	2007-06-06	株式会社ファンケル	表皮の偏平化を予防、防止、改善する皮膚老化防止用組成物
EP1407760A1 (de) *	2002-10-08	2004-04-14	Cognis France S.A.	Verfahren zum Schutz der Haut gegen Alterung
US20070243271A1 (en) *	2003-01-13	2007-10-18	Steven Hernandez	Use of polyphenols to treat skin conditions
US20040202732A1 (en) *	2003-04-11	2004-10-14	Brown William Stewart	Composition to promote weight loss
US20050053631A1 (en) *	2003-09-10	2005-03-10	Unilever Home & Personal Care Usa, Division Of Conopco, Inc.	Method of decreasing sebum production
US20050152857A1 (en) *	2004-01-08	2005-07-14	Pcr Technology Holdings, Lc	Method and preparation for reducing sunburn cell formation in skin
US20050175559A1 (en) *	2004-02-10	2005-08-11	Pcr Technology Holdings, Lc	Method and preparation for reducing skin hyperpigmentation
EP1651199A4 (de) *	2004-02-13	2008-08-20	Pcr Technology Holdings Lc	Verfahren und zubereitung zur verminderung der irritation und/oder der entzündungsreaktion der menschlichen haut
US7635669B2 (en)	2004-10-04	2009-12-22	Afton Chemical Corportation	Compositions comprising at least one hydroxy-substituted carboxylic acid
BRPI0519445A2 (pt) *	2005-01-14	2009-01-20	Lipo Chemicals Inc	composiÇço, formulaÇço de cuidado da pele, mÉtodos para tratar peles de humano e de memÍfero, para prevenir pele de mamÍfero hiperpigmentada, e para praparar uma composiÇço de clareamento da pele
JP2008540350A (ja) *	2005-05-03	2008-11-20	ユニリーバー・ナームローゼ・ベンノートシヤープ	共役リノール酸およびナイアシンアミドを含む美白組成物
JP5192380B2 (ja) *	2005-09-08	2013-05-08	株式會社アモーレパシフィック	皮膚老化防止用皮膚外用剤組成物
US7175835B1 (en)	2005-12-23	2007-02-13	Conopco, Inc.	Cosmetic emulsions with inorganic sunscreens stabilized with conjugated linoleic acid
US7172754B1 (en)	2005-12-23	2007-02-06	Conopco, Inc.	Cosmetic emulsions with sunscreens and conjugated linoleic acid
US7175836B1 (en)	2005-12-23	2007-02-13	Conopco, Inc.	Oil continuous phase cosmetic emulsions with conjugated linoleic acid
ES2283212B1 (es)	2006-03-31	2008-08-16	Lipotec S.A.	Peptidos sinteticos utiles en el tratamiento de la piel y su uso en composiciones cosmeticas o dermofarmaceuticas.
FI20060729A0 (fi) *	2006-08-14	2006-08-14	Oy Granula Ab Ltd	Ihon- tai karvanhoitokoostumus tai sen valmistuksessa käytetty puolivalmiste
EP1958611A1 (de) *	2006-12-20	2008-08-20	DSMIP Assets B.V.	Orale Zusammensetzung mit EGCG und Lycopin
KR100883757B1 (ko) *	2007-03-12	2009-02-12	성균관대학교산학협력단	신경전달물질 배출을 조절하기 위한 폴리페놀 화합물
US8734867B2 (en)	2007-12-28	2014-05-27	Liveleaf, Inc.	Antibacterial having an extract of pomegranate combined with hydrogen peroxide
JP5490020B2 (ja) *	2008-01-24	2014-05-14	ヴァイティーファーマシューティカルズ，インコーポレイテッド	１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状カルバゼート及びセミカルバジドインヒビター
DK2403938T3 (da) *	2009-03-04	2020-03-16	Liveleaf Inc	Fremgangsmåde og materiale til stedaktiveret kompleksdannelse af biologiske molekyler
FR2949065B1 (fr) *	2009-08-17	2011-10-21	Natura Cosmeticos Sa	Complexe eclaircissant la peau, utilisation dudit complexe, composition cosmetique ou pharmaceutique comprenant ledit complexe et procede pour son application
US20110190186A1 (en) *	2010-02-02	2011-08-04	University Of New Brunswick	Skin cleansing system and method
US20110214318A1 (en) *	2010-03-05	2011-09-08	Sony Ericsson Mobile Communications Ab	Paper Stock Card with Wireless Communication Capability
EA023896B1 (ru)	2010-05-18	2016-07-29	Юнилевер Н.В.	Композиция для отбеливания кожи, содержащая экстракт desmodium gangeticum
US8722040B2 (en)	2011-06-24	2014-05-13	Liveleaf, Inc.	Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
US9192635B2 (en)	2011-06-24	2015-11-24	Liveleaf, Inc.	Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide
KR101324654B1 (ko) *	2011-09-30	2013-11-04	강원대학교산학협력단	에스쿨레틴을 유효성분으로 포함하는 주름 개선 및 항노화용 화장료 조성물
US8716351B1 (en)	2012-12-23	2014-05-06	Liveleaf, Inc.	Methods of treating gastrointestinal spasms
WO2016085302A1 (ko) *	2014-11-28	2016-06-02	(주)아모레퍼시픽	제니스테인 또는 에피갈로카테친 갈레이트를 포함하는 세포 회춘 촉진 유도용 조성물
TWI555537B (zh) *	2015-05-21	2016-11-01	張德生	3’-羥基染料木黃酮用於製備抑制黑色素生成之組合物的用途
CN112654398A (zh)	2018-08-06	2021-04-13	联合利华知识产权控股有限公司	局部组合物
CN112730017B (zh) *	2021-01-07	2024-06-25	中国计量大学	挥发油复配增溶剂及挥发油酪氨酸酶活性抑制的测定方法
CN114288281A (zh) *	2021-12-07	2022-04-08	上海中医药大学附属岳阳中西医结合医院	三亚油酸甘油酯在制备预防和/或治疗特应性皮炎的药物中的应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2474310A1 (fr) *	1980-01-25	1981-07-31	Oreal	Solution stable a l'oxydation de vitamine f et d'huile de jojoba et compositions cosmetiques la contenant
JP2614474B2 (ja) *	1988-01-20	1997-05-28	サンスター株式会社	美白化粧料
JP3170024B2 (ja) *	1992-02-03	2001-05-28	サンスター株式会社	美白化粧料
JPH05271046A (ja) *	1992-03-26	1993-10-19	Lion Corp	皮膚外用剤
FR2694692B1 (fr) *	1992-08-13	1994-10-28	Thorel Jean Noel	Préparation cosmétique de nutrition de la peau.
GB9223235D0 (en)	1992-11-05	1992-12-16	Unilever Plc	Cosmetic composition
JP3364773B2 (ja) *	1994-09-30	2003-01-08	株式会社コーセー	皮膚外用剤
MY118354A (en) *	1995-05-01	2004-10-30	Scarista Ltd	1,3-propane diol derivatives as bioactive compounds
US5951990A (en) *	1995-05-15	1999-09-14	Avon Products, Inc.	Ascorbyl-phosphoryl-cholesterol
MX9709154A (es) *	1995-05-26	1998-03-31	Unilever Nv	Regimen de tratamiento para la piel.
CA2233222C (en)	1996-02-23	2003-07-08	Unilever Plc	Skin treatment with salicylic acid esters and retinoids
JPH09255526A (ja) *	1996-03-27	1997-09-30	Shiseido Co Ltd	老化防止化粧料
JP4040129B2 (ja) *	1996-05-27	2008-01-30	株式会社エルブ	外用組成物に配合するための微粉化複合体および外用組成物
US5690947A (en) *	1996-08-30	1997-11-25	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
GB9620248D0 (en) *	1996-09-26	1996-11-13	Scotia Holdings Plc	Esters of unsaturated fatty acids
US5665367A (en) *	1996-09-27	1997-09-09	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Skin care compositions containing naringenin and/or quercetin and a retinoid
GB9621630D0 (en) *	1996-10-17	1996-12-11	Kappa Pharmaceuticals Ltd	Treatment of skin disorders
US5728732A (en)	1996-11-27	1998-03-17	Elizabeth Arden Company, Division Of Conopco, Inc.	Skin treatment with salicylic acid esters and retinoids
JPH10212477A (ja) *	1997-01-29	1998-08-11	Nippon Surfactant Kogyo Kk	Ｏ／ｗ型エマルジョンの酸化防止方法、抗酸化剤組成物及びｏ／ｗ型エマルジョン
US5855893A (en) *	1997-02-14	1999-01-05	Elizabeth Arden Co., Division Of Conopco, Inc.	Trichodesma lanicum seed extract as an anti-irritant in compositions containing hydroxy acids or retinoids
FR2762512B1 (fr) *	1997-04-24	2000-10-13	Pharmascience Lab	Compositions a base d'huile de lupin, notamment a base d'huile de lupin et d'huile de germe de ble et leur utilisation en cosmetologie, en pharmacie et en tant que complement alimentaire
DE19718245C5 (de) *	1997-04-30	2004-11-11	Cognis Deutschland Gmbh & Co. Kg	Synthetische Triglyceride auf Basis konjugierter Linolsäure, Verfahren zu deren Herstellung und deren Verwendung
JP3386989B2 (ja) *	1997-11-10	2003-03-17	花王株式会社	化粧料
US6019990A (en)	1997-11-21	2000-02-01	Natural Nutrition Ltd. As	Conjugated linoleic acid delivery system in cosmetic preparations
US6136985A (en) *	1997-12-23	2000-10-24	Dcv, Inc.	CLA esters and uses thereof
US6180120B1 (en) *	1998-12-08	2001-01-30	Elizabeth Arden Co., Division Of Conopco, Inc.	Cosmetic skin care compositions containing alpha hydroxy acids linoleates
GB9828379D0 (en) *	1998-12-22	1999-02-17	Unilever Plc	Skin care composition
US6296861B1 (en) *	1999-05-03	2001-10-02	Nicholas V. Perricone	Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters

1999
- 1999-07-30 GB GBGB9918028.3A patent/GB9918028D0/en not_active Ceased
2000
- 2000-07-11 KR KR1020027001259A patent/KR100729315B1/ko not_active Expired - Fee Related
- 2000-07-11 MX MXPA02001028A patent/MXPA02001028A/es active IP Right Grant
- 2000-07-11 AU AU69855/00A patent/AU776606B2/en not_active Ceased
- 2000-07-11 AT AT00958279T patent/ATE304841T1/de not_active IP Right Cessation
- 2000-07-11 CA CA002391343A patent/CA2391343C/en not_active Expired - Lifetime
- 2000-07-11 DE DE60022758T patent/DE60022758T2/de not_active Expired - Lifetime
- 2000-07-11 EP EP00958279A patent/EP1198222B1/de not_active Expired - Lifetime
- 2000-07-11 ES ES00958279T patent/ES2248109T3/es not_active Expired - Lifetime
- 2000-07-11 JP JP2001513382A patent/JP2003505492A/ja active Pending
- 2000-07-11 WO PCT/EP2000/006597 patent/WO2001008652A1/en not_active Ceased
- 2000-07-11 CN CNB008132739A patent/CN1195492C/zh not_active Expired - Lifetime
- 2000-07-28 US US09/627,965 patent/US6551602B1/en not_active Expired - Lifetime
- 2000-08-29 TW TW089117493A patent/TWI230071B/zh not_active IP Right Cessation
2002
- 2002-01-22 ZA ZA200200552A patent/ZA200200552B/en unknown

Also Published As

Publication number	Publication date
KR100729315B1 (ko)	2007-06-19
DE60022758D1 (de)	2005-10-27
ATE304841T1 (de)	2005-10-15
GB9918028D0 (en)	1999-09-29
JP2003505492A (ja)	2003-02-12
EP1198222A1 (de)	2002-04-24
AU6985500A (en)	2001-02-19
EP1198222B1 (de)	2005-09-21
KR20020013978A (ko)	2002-02-21
TWI230071B (en)	2005-04-01
CA2391343C (en)	2009-11-03
WO2001008652A1 (en)	2001-02-08
MXPA02001028A (es)	2002-08-12
CA2391343A1 (en)	2001-02-08
ES2248109T3 (es)	2006-03-16
US6551602B1 (en)	2003-04-22
DE60022758T2 (de)	2006-07-27
CN1195492C (zh)	2005-04-06
CN1376050A (zh)	2002-10-23
AU776606B2 (en)	2004-09-16

Publication	Publication Date	Title
AU776606B2 (en)	2004-09-16	Skin care composition
US6455057B1 (en)	2002-09-24	Skin care composition
JP2003505492A5 (de)	2010-04-30
EP1200059B1 (de)	2003-10-01	Hautpflegezusammensetzung
EP1140003B1 (de)	2010-09-29	Cis-9, trans-11 linolsäure enthaltende hautpflegemittel
CA2322233C (en)	2010-02-02	Cosmetic method of treating skin
US6042841A (en)	2000-03-28	Cosmetic method of treating skin
US20030039672A1 (en)	2003-02-27	Cosmetic composition and method of treating skin
AU2002324040A1 (en)	2003-06-19	Cosmetic composition and method of treating skin